Skip to main content

Stigmabase | HIV

Updates & Legacy — Stigmabase is a Canadian Non-Governmental & Nonprofit Initiative. Our mission is to inform about stigma around the world and make the data collected accessible for researchers. Stigmabase is very attentive to misinformation and lists only reliable sources. — The marginalization of individuals or categories of individuals is a too common phenomenon. Millions of people are facing this problem around the world and many complex factors are involved.

|

Dexter's Laura Merz following her dream to work in poverty-stricken Liberia

South Africa Time — Sunday, February 06, 2011

Dexter's Laura Merz following her dream to work in poverty-stricken Liberia: "Laura Merz of Dexter will spend 20 hours in a plane today en route to Liberia, Africa, where she'll work most of the next three months in Conia, ...

LEGACY - for researchers

Top stories of the last 30 days

Misinformation threatens rollout of HIV prevention drug lenacapavir

South Africa Time — Wednesday, May 27, 2026

Health experts say false claims about the lenacapavir injection could undermine efforts to reduce new HIV infections in South Africa. View article...

Maraviroc as an Immunomodulatory Drug for Antiretroviral-treated HIV Infected Patients ...

South Africa Time — Thursday, May 28, 2026

In this study, HIV-infected patients who are receiving antiretroviral therapy for HIV will receive either maraviroc or a placebo (sugar pill) each day ... View article...

Genotypic challenges in implementing broadly neutralizing antibody-based long-acting HIV ...

South Africa Time — Thursday, May 28, 2026

Broadly neutralizing antibodies (bnAbs) against HIV-1 are promising components of long-acting antiretroviral treatment (ART) due to their ... View article...

Immuno Cure Deploys Scientist Team to Manage Research Facility for Therapeutic DNA ...

South Africa Time — Wednesday, May 27, 2026

... HIV infection, with over 44.1 million people living with HIV globally. While antiretroviral therapy can effectively control HIV replication, it ... View article...

Integrating HIV Prevention Tools for Men

South Africa Time — Thursday, May 28, 2026

HIV continues to be a major public health challenge in Sub-Saharan Africa, where a large share of global infections still occur. View article...

Misinformation is coming for the anti-HIV jab. Let's get ahead of it

South Africa Time — Monday, May 25, 2026

A new HIV prevention injection could change the course of the epidemic — but only if people trust it. Research shows we can pre-empt the false ... View article...

Consistency in causal reasoning for large language models in scenarios of HIV antiretroviral ...

South Africa Time — Thursday, May 28, 2026

LLMs were prompted with context-rich clinical and causal vignettes to generate use cases, followed by context-simple ... View article...

One community health worker's mission to stop advanced HIV disease in Uganda

South Africa Time — Wednesday, May 27, 2026

CD4 testing works alongside another tool Margaret relies on: viral load testing, which measures the amount of HIV in the blood. The two tests answer ... View article...

JOHANNESBURG

Stigmabase is a canadian non-profit internet initiative dedicated to informing and raising awareness on the damaging effects of social exclusion and stigma around the world. The marginalization of individuals or categories of individuals is a too common phenomenon. Millions of people are facing this problem around the world and many complex factors are involved.

Powered by Blogger

2010 - 2026 ― Stigmabase Global Initiative || Keeping up-to-date on global exclusion

Top stories of the last 7 days

GLP-1 drugs like Ozempic, Wegovy may help slow biological aging

South Africa Time — Wednesday, June 10, 2026

In a trial of adults living with HIV , participants receiving semaglutide showed slower progression of several epigenetic markers associated with ... View article...

Will HIV Win and Lung Cancer Loss in Trials Recast Merck's (MRK) Risk Reward Narrative?

South Africa Time — Tuesday, June 09, 2026

In early June 2026, Gilead Sciences and Merck reported that their investigational once-weekly oral HIV regimen of islatravir/lenacapavir met the ... View article...

Annual epidemiological spotlight on HIV in London: 2023 data

South Africa Time — Thursday, June 11, 2026

HIV remains an important public health issue in London. After a long period when diagnoses were declining, we have seen increases in recent years. View article...

Healthcare Access: Challenges and Solutions for Uninsured LGBTQ+

South Africa Time — Thursday, June 11, 2026

Lack of access to HIV and other STI testing, trouble finding a primary care physician, and homelessness are just some of the roadblocks that LGBTQ+ ... View article...

Study explains why HIV sometimes persists in blood post-treatment

South Africa Time — Tuesday, June 09, 2026

... antiretroviral drug therapy. These samples, which were assessed from 32 ... Modern antiretroviral therapies, which date back to 1996, prevent ... View article...

FG unveils HIV strategy to cut donor dependence

South Africa Time — Thursday, June 11, 2026

The Federal Government has unveiled a new National HIV and AIDS Strategic Plan (NSP) 2026–2030 aimed at shifting Nigeria's HIV response from heavy ... View article...

Ravunawa says 80% of HIV-positive patients not taking medication or returning to replenish supply

South Africa Time — Wednesday, June 10, 2026

Assistant Minister for Health Penioni Ravunawa says almost 80 percent of people who have tested positive for HIV are either not taking their ... View article...

Motsoaledi says Lenacapavir is safe, debunks claims it causes HIV or cancer

South Africa Time — Thursday, June 11, 2026

Health Minister Dr Aaron Motsoaledi has rejected misinformation that lenacapavir causes HIV or cancer, telling Parliament the HIV prevention ... View article...

ABOUT STIGMABASE
Request for Review

Total Pageviews